Medical Center St. Ivan Rilski Chudotvorets 2010 EOOD
- Address
- lock Available on a paid plan
Medical Center St. Ivan Rilski Chudotvorets 2010 EOOD
Medical Center St. Ivan Rilski Chudotvorets 2010 EOOD is a clinical research facility specializing in evaluating novel therapeutic interventions across gastroenterology and infectious disease. The center demonstrates expertise in conducting Phase II/III trials for innovative biologic and antiviral therapies, with a focus on patient populations requiring specialized care and monitoring.
- Inflammatory Bowel Disease research, particularly moderately to severely active Crohn's Disease
- Infectious disease therapeutics, including COVID-19 antiviral treatment development
- High-risk patient populations requiring outpatient therapeutic interventions
The facility's research portfolio includes evaluating novel biologic agents such as afimkibart for Crohn's Disease induction therapy and protease inhibitors like ibuzatrelvir for COVID-19 management in non-hospitalized patients at high risk for disease progression. This dual focus on chronic inflammatory conditions and acute infectious diseases positions the center as a versatile research site capable of managing complex clinical trial protocols across diverse therapeutic areas.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1AstraZeneca AB2active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medical Center St. Ivan Rilski Chudotvorets 2010 EOOD
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicentre, Parallel-group, Phase IIb, Randomised, Double blind, Placebo-controlled, 4-Arm, 24-Week Study to Evaluate the Efficacy and Safety of AZD6793 Tablets in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (PRESTO). | AstraZeneca AB | Phase II | Recruiting | Sep 2025 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ro7790121 | 2 | Unknown | 2025-01-09 | 2025-04-16 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.